產(chǎn)品編號(hào) | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購(gòu)物車 | |
---|---|---|---|---|---|
Brivudine,98% | C11H13BrN2O5 | ||||
|
|||||
Lincomycin hydrochloride,98% | C18H34N2O6S · HCl · H2O | ||||
|
|||||
Oxacillin Sodium Monohydrate,99% | C19H18N3NaO5S | ||||
|
|||||
BMS-707035,99% | C17H19FN4O5S | ||||
|
|||||
Fenticonazole Nitrate,≥99% | C24H21Cl2N3O4S | ||||
|
|||||
Solithromycin,99% | C43H65FN6O10 | ||||
|
|||||
Azathramycin,98% | C37H70N2O12 | ||||
|
|||||
Danoprevir,97% | C35H46FN5O9S | ||||
|
|||||
MK-2048,98% | C21H21ClFN5O4 | ||||
|
|||||
Raltegravir Potassium Salt,99% | C20H20FKN6O5 | ||||
|
|||||
Sertaconazole Nitrate,≥98% | C20H16Cl3N3O4S | ||||
|
|||||
Tegobuvir,97% | C25H14F7N5 | ||||
|
|||||
AAI101,98% | C11H14N4O5S | ||||
|
|||||
Daclatasvir (BMS-790052),99% | C40H50N8O6 | ||||
|
|||||
Cadazolid,98% | C29H29F2N3O8 | ||||
|
|||||
Rufloxacin hydrochloride,99% | C17H19ClFN3O3S | ||||
|
|||||
beta-lactamase-IN-1,98% | C11H13N3O4 | ||||
|
|||||
N-Acetyl-Calicheamicin,98% | C57H76IN3O22S4 | ||||
|
|||||
Magainin II,98% | C114H180N30O29S | ||||
|
|||||
PLpro inhibitor,98% | C22H22N2O2 | ||||
|